Seeing Is Believing
KALA is currently covered by 4 analysts with an average price target of $281.38. This is a potential upside of $274.98 (4296.56%) from yesterday's end of day stock price of $6.4.
Kala Pharmaceuticals's activity chart (see below) currently has 10 price targets and 41 ratings on display. The stock rating distribution of KALA is 93.75% BUY and 6.25% SELL.
Analysts average stock forecasts to be materialized ratio is 5.73% with an average time for these price targets to be met of 26.63 days.
Highest price target for KALA is $22, Lowest price target is $15, average price target is $281.38.
Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 02-Apr-2024. First documented stock forecast 25-Oct-2017.
Currently out of the existing stock ratings of KALA, 15 are a BUY (93.75%), 1 are a SELL (6.25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
15
$8.67 (136.97%)
15
22 days ago
0/3 (0%)
$7.01 (87.73%)
Buy
21
$14.67 (231.75%)
22
22 days ago
1/8 (12.5%)
$13.01 (162.83%)
65
Buy
22
$15.67 (247.55%)
47
5 months 10 days ago
0/2 (0%)
$16.8 (323.08%)
Buy
1 years 8 months 9 days ago
0/2 (0%)
$390 (108.33%)
Sell
75
$68.67 (1084.83%)
2 years 25 days ago
0/2 (0%)
$2 (2.74%)
What is KALA (Kala Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?